Brain HealthGut Inflammation Triggers Brain Cell Loss — and a Drug May Stop It
People with inflammatory bowel disease face a higher risk of developing Parkinson's disease, but scientists haven't fully understood why. A new study in mice shows that chronic gut inflammation triggers a damaging immune response deep in the brain's midbrain region, leading to the loss of dopamine-producing neurons — the cells destroyed in Parkinson's. Researchers found that blocking a receptor called CSF1R, which controls a class of immune cells called myeloid cells, reduced brain inflammation and completely prevented dopaminergic neuron loss. The gut inflammation itself was unaffected, suggesting this approach targets the brain-specific damage rather than the bowel disease. This identifies a concrete cellular pathway linking gut inflammation to Parkinson's-like neurodegeneration and points toward a potential neuroprotective drug strategy for IBD patients.
